- Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressantHeather V Krell
Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024 1759, USA
J Clin Psychiatry 65:1174-9. 2004..To evaluate the association between treatment expectations and response in a 9-week, single-blind experimental antidepressant treatment study...
- Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back painHeather V Krell
Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, 37 452 NPI, 760 Westwood Plaza, Los Angeles, CA 90024, USA
Psychosomatics 46:379-84. 2005..Our experience with reboxetine suggests that this noradrenergic antidepressant may have efficacy in the treatment of chronic pain in patients with depression...